The CBLC antibody from Wuhan Fine Biotech Co., Ltd. is a Rabbit Polyclonal antibody to Cbl proto-oncogene C, and CBLC. This antibody recognizes Homo Sapiens, Human, Mouse, and Rat antigen. The CBLC antibody has been validated for the following applications: EIA, Immunoassay, ELISA, and Western Blot.
Description
Acts as an E3 ubiquitin-protein ligase, which accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes, and then transfers it to substrates promoting their degradation by the proteasome. Functionally coupled with the E2 ubiquitin-protein ligases UB2D1, UB2D2 and UB2D3. Regulator of EGFR mediated signal transduction; upon EGF activation, ubiquitinates EGFR. Isoform 1, but not isoform 2, inhibits EGF stimulated MAPK1 activation. Promotes ubiquitination of SRC phosphorylated at 'Tyr-419'. In collaboration with CD2AP may act as regulatory checkpoint for Ret signaling by modulating the rate of RET degradation after ligand activation; CD2AP converts it from an inhibitor to a promoter of RET degradation; the function limits the potency of GDNF on neuronal survival